Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • aloliveira
    Member
    • Aug 2010
    • 47

    454 downstream analysis.

    Hello,

    I am working with 454 data and i have few question about the downstream analysis.

    1) My data contains the adaptors sequences so i have to trimm these sequences out. How i proceed to do this?

    2) I have reads with the adaptor and reads that did not have the adaptors sequences. How it's is possible i has reads with no adaptor if the adaptor itself who permits the sequencing reaction?

    3) I discard the non-adaptors reads?

    Best wishes,
    André
  • maubp
    Peter (Biopython etc)
    • Jul 2009
    • 1544

    #2
    Are you using the Roche "Newbler" tools? If so, you just provide you adapters or PCR primers in a FASTA file. And Roche already knows about their standard adapters and barcodes, so that is really easy.

    Comment

    • aloliveira
      Member
      • Aug 2010
      • 47

      #3
      Hy maubp,

      I dont have the Newbler license. But i already know how to solve my problem. Anyway do you know the aswer for the second question? I dont know how its possible exists a read without adaptor sequence.

      Thank you,
      André

      Comment

      • maubp
        Peter (Biopython etc)
        • Jul 2009
        • 1544

        #4
        What kind of adapters?

        What kind of downstream analysis (e.g. Mapping to a reference, de novo assembly, or reference guided assembly)?

        Comment

        • kmcarr
          Senior Member
          • May 2008
          • 1181

          #5
          Originally posted by aloliveira View Post
          Hello,

          I am working with 454 data and i have few question about the downstream analysis.

          1) My data contains the adaptors sequences so i have to trimm these sequences out. How i proceed to do this?

          2) I have reads with the adaptor and reads that did not have the adaptors sequences. How it's is possible i has reads with no adaptor if the adaptor itself who permits the sequencing reaction?

          3) I discard the non-adaptors reads?

          Best wishes,
          André
          André,

          Do you mean the 454 adapters themselves? You should never see these in your final reads. There are two primary reasons why you should not see them:

          1) The sequencing primer starts at the keytag of the 3' end of the template (5' end of the output read) and then immediately proceeds into the inserted DNA. The software trims the keytag before outputting the final sequence so there is really no chance of having 454 adapter sequence at the 5' end of your read.

          2) The library construction protocol should produce inserts which are longer than the average read length, it is unlikely that the read will reach the end of the insert and thus proceed into the 454 adapter at the 5' end of the template (3' end of the read). If by chance an insert is short and sequencing proceeds into the downstream adapter the 454 software will detect this and trim any adapter from the 3' end of your read.

          Your final sequences thus should not contain the 454 adapters. If your library construction method used custom adapters then that is a different matter.

          Originally posted by aloliveira View Post
          Hy maubp,

          I dont have the Newbler license.
          André
          The Roche/454 Data Analysis software tools are available free upon request. You can request them from 454 at this website.

          Comment

          • Himalaya
            Member
            • Jun 2010
            • 38

            #6
            newbler quality trimming

            Hi All
            Does anyone has tried to do the quality trimming of 454 short sequence reads? My 454 short sequence reads are already trimmed for adaptors and MIDs. But there are poor quality bases that I wanted to trim. Anyone please help me out to do quality trim with Newbler...

            Himalaya

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            31 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            214 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            79 views
            0 reactions
            Last Post SEQadmin2  
            Working...